Our study describes novel models for studying LEF1 function in T-ALL and indicate that LEF1 is a modulator of leukemic transformation providing both addictive and inhibitory functions depending on its availability during transformation. This evidence concerns the gene LEF1 and acute lymphoblastic leukemia.